(Q67977523)
Statements
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder (English)
W. W. Fleischhacker
H. Hinterhuber
H. Bauer
B. Pflug
P. Berner
C. Simhandl
R. Wolf
W. Gerlach
H. Jaklitsch
M. Sastre-y-Hernández
1 January 1992